The global demand for Insomnia Market is presumed to reach the market size of nearly USD 7.77 MN by 2028 from USD 5.56 MN in 2021 with a CAGR of 4.9% under the study period 2022 - 2028.
Insomnia is a sleep condition wherein a person finds it difficult to fall asleep or stay asleep. Low stamina, daytime tiredness, depression, and irritability are some symptoms. It is a widespread condition that affects millions of people worldwide. Circadian rhythm disruption, chronic pain, hyperthyroidism, menopause, psychological stress, and other medical disorders can contribute to insomnia. Excessive medications like caffeine, alcohol and nicotine can also cause sleeplessness. Various diagnostic equipment can be used in sleep laboratories to diagnose this problem. Insomnia is classified into three categories based on how long it lasts: transitory, acute, and chronic insomnia. The symptoms of transient insomnia extend from a few days to a few weeks; acute insomnia lasts for many weeks, and chronic insomnia lasts for months to years.
Market Dynamics
People are currently experiencing much stress at work, which is leading to tension, continual thinking, and sleep deprivation, hence driving the insomnia market growth. In addition, there is a high demand for over-the-counter medications among the various age groups of patients who have insomnia. Additionally, the increased prevalence of insomnia among people due to a variety of factors such as strain and stress is expected to be important drivers for the global expansion of the insomnia market. The availability of pharmacological and non-pharmacological treatments on a large scale is further assisting the insomnia market's growth.
The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of insomnia. The growth and trends of insomnia industry provide a holistic approach to this study.
Market Segmentation
This section of the insomnia market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
By Therapy Type
- Non-pharmacological Therapy
- Hypnotherapy
- Cognitive Behavioral Therapy
- Medical Devices
- Other Non-pharmacological Therapy
- Pharmacological Therapy
- Prescription Sleep Aids
- Over-the-counter Sleep Aids
Regional Analysis
This section covers the regional outlook, which accentuates current and future demand for the Insomnia market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
Global Insomnia Market Share by Region (Representative Graph)
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the insomnia market include Merck & Co. Inc., Sanofi, Pfizer, Inc., Takeda Pharmaceutical Company Ltd., Purdue Pharmaceuticals L.P., Eisai, Co. Ltd., Meda Consumer Healthcare Inc., Pernix Therapeutics, Vanda Pharmaceuticals, and ECR Pharmaceuticals. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.